1.
Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992–2015
by Childs, Lana
Vaccine, 2018-01-02, Vol.36 (1), p.6-14
2.
Viral hepatitis B
by Lai, Ching Lung
The Lancet (British edition), 2003-12-20, Vol.362 (9401), p.2089-2094
3.
Progress towards hepatitis B prevention through vaccination in the Western Pacific, 1990–2014
by Wiesen, Eric
Vaccine, 2016, Vol.34 (25), p.2855-2862
4.
Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada
by Huynh, Chris
Vaccine, 2017-08-16, Vol.35 (35), p.4515-4522
5.
Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China
by Zhang, H W
Gut, 2008-12, Vol.57 (12), p.1713-1720
6.
Hepatitis B control among children in the Eastern Mediterranean Region of the World Health Organization
by Allison, Robert D
Vaccine, 2016, Vol.34 (21), p.2403-2409
7.
Progress towards achieving hepatitis B control in the Cook Islands, Niue, Tokelau, and Kiribati
by Patel, Minal K
Vaccine, 2016, Vol.34 (36), p.4298-4303
8.
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews
by Nelson, Paul K, MHSc
The Lancet (British edition), 2011, Vol.378 (9791), p.571-583
9.
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
by Dolan, Kate, Prof
The Lancet (British edition), 2016, Vol.388 (10049), p.1089-1102
10.
Seroepidemiology of hepatitis B virus infection in 2 million men aged 21–49 years in rural China: a population-based, cross-sectional study
by Liu, Jue, PhD
The Lancet infectious diseases, 2016, Vol.16 (1), p.80-86
11.
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013
by Degenhardt, Louisa, Prof
The Lancet infectious diseases, 2016, Vol.16 (12), p.1385-1398
12.
Hepatitis B virus infection
by Trépo, Christian, Prof
The Lancet (British edition), 2014, Vol.384 (9959), p.2053-2063
13.
Changing epidemiology of hepatocellular carcinoma in Asia
by Goh, George Boon-Bee, MBBS, MMed, MRCP (UK)
Baillière's best practice & research. Clinical gastroenterology, 2015, Vol.29 (6), p.919-928
14.
Control of hepatitis B in China: prevention and treatment
by Wang, Yu
Expert review of anti-infective therapy, 2011-01-01, Vol.9 (1), p.21-25
15.
Requirements for global elimination of hepatitis B: a modelling study
by Nayagam, Shevanthi, Dr
The Lancet infectious diseases, 2016, Vol.16 (12), p.1399-1408
16.
Epidemiological serosurvey of Hepatitis B in China—Declining HBV prevalence due to Hepatitis B vaccination
by Liang, Xiaofeng
Vaccine, 2009, Vol.27 (47), p.6550-6557
17.
Difference of hepatitis B virus genotype distribution in two groups of mexican patients with different risk factors. High prevalence of genotype H and G
by Sánchez, L V
Intervirology, 2007, Vol.50 (1), p.9-15
18.
Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000
by MORLAT, Philippe
AIDS (London), 2014, Vol.28 (8), p.1181-1191
19.
Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2008
by Satterwhite, Catherine Lindsey
Sexually transmitted diseases, 2013-03-01, Vol.40 (3), p.187-193
20.
Hepatitis B, hepatitis C and mortality among HIV-positive individuals
by Thornton, Alicia C
AIDS (London), 2017-09-18, Vol.31 (18), p.2525-2532
